The present application provides methods for analyzing and purifying
degarelix or a pharmaceutically acceptable salt thereof containing at least one related
impurity. Methods for analyzing and purifying
degarelix or a pharmaceutically acceptable salt thereof containing
Compound A and / or Compound D as impurities are also provided. Further provided are
degarelix or a pharmaceutically acceptable salt thereof prepared and / or selected using the disclosed methods.